Buy or sell Enliven Therapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Enliven Therapeutics Stock

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

About Enliven Therapeutics Stock

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives. The company's discovery process combines clinically validated biological targets and industry-leading chemistry to address the limitations of existing therapies. This approach allows us to efficiently and effectively develop precision oncology therapeutics that enhance overall patient well-being. Founded in July 2019 by Sam Kintz, MBA, Joe Lyssikatos, PhD, and Anish Patel, PharmD, Enliven Therapeutics is based in Boulder, Colorado.

Funding History

December 2020$55.0M
January 2022$85.0M

Management

Co-Founder and CEO

Sam Kintz

Co-founder and Chief Operating Officer

Anish Patel

Co-founder and Chief Scientific Officer

Joe Lyssikatos

Board Member

Rich Heyman

Board Member

Mika Derynck

Board Member

Andrew Phillips

Board Member

Jake Bauer

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 280K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo